A once-daily injectable used to improve glycemic control in adults with type 2 diabetes as an adjunct to diet and exercise. It combines the long-acting basal insulin effect with the glucose-lowering and weight-modulating effects of a GLP-1 receptor agonist.Indications:- Improve glycemic control in adults with type 2 diabetes when diet and exercise alone are insufficient.- Can be used in patients inadequately controlled on basal insulin or GLP-1 receptor agonists.Main Active Ingredients:- Insulin degludec 100 units/mL.- Liraglutide 3.6 mg/mL.Precautions:- Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome.- Do not use during episodes of hypoglycemia.- Monitor for signs of thyroid C-cell tumors, pancreatitis, severe gastrointestinal reactions, or hypersensitivity.- Avoid sharing injection pens.- Monitor kidney function during episodes of dehydration.- Adjust insulin regimen carefully to avoid hypo- or hyperglycemia.Side Effects:- Nasopharyngitis.- Headache.- Nausea.- Diarrhea.- Increased lipase.- Upper respiratory tract infection.- Hypoglycemia (common with insulin-containing products).- Pancreatitis.Drug-Drug Interactions:- Anti-adrenergic drugs, such as metoprolol, atenolol, propranolol (beta-blockers), and clonidine, may reduce awareness of hypoglycemia.- Concomitant oral medications, such as paracetamol (acetaminophen), ethinylestradiol/norgestimate (oral contraceptives), and amoxicillin, doxycycline (antibiotics), may have altered absorption due to delayed gastric emptying caused by liraglutide.

- Administer once daily by subcutaneous injection at the same time each day.
- Follow instructions on injection technique and rotate injection sites.
- Take the dose exactly as prescribed by a healthcare professional.

• Anti-diabetic

Insulin Degludec, Liraglutide, Glycerol, Phenol, Disodium Phosphate Dihydrate, Sodium Chloride, Hydrochloric Acid, Sodium Hydroxide, Water for Injection.